Last reviewed · How we verify

vaccinated with Sabin IPV — Competitive Intelligence Brief

vaccinated with Sabin IPV (vaccinated with Sabin IPV) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Immunology.

marketed vaccine poliovirus serotypes 1, 2, and 3 Immunology Biologic Live · refreshed every 30 min

Target snapshot

vaccinated with Sabin IPV (vaccinated with Sabin IPV) — Zhejiang Provincial Center for Disease Control and Prevention. Sabin IPV (inactivated polio vaccine) stimulates the immune system to produce antibodies against all three poliovirus serotypes, preventing poliomyelitis infection.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
vaccinated with Sabin IPV TARGET vaccinated with Sabin IPV Zhejiang Provincial Center for Disease Control and Prevention marketed vaccine poliovirus serotypes 1, 2, and 3
fIPV (0.1mL) IM fIPV (0.1mL) IM Centers for Disease Control and Prevention marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
IPV-Al IPV-Al AJ Vaccines A/S marketed Inactivated viral vaccine Poliovirus serotypes 1, 2, and 3
Sabin IPV Sabin IPV Centers for Disease Control and Prevention, China marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
Sabin IPV + Sabin IPV + Sabin IPV Sabin IPV + Sabin IPV + Sabin IPV Zhejiang Provincial Center for Disease Control and Prevention marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
IPV SSI IPV SSI Statens Serum Institut phase 3 Inactivated viral vaccine Poliovirus serotypes 1, 2, and 3
Comirnaty BNT162b2 (tozinameran) Pfizer Inc. marketed vaccine SARS-CoV-2 virus 2021-08-23

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (vaccine class)

  1. Pfizer · 20 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
  3. GlaxoSmithKline · 12 drugs in this class
  4. Merck Sharp & Dohme LLC · 12 drugs in this class
  5. Centers for Disease Control and Prevention · 9 drugs in this class
  6. Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
  7. Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
  8. Beijing Center for Disease Control and Prevention · 6 drugs in this class
  9. International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
  10. Sinovac Biotech Co., Ltd · 4 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). vaccinated with Sabin IPV — Competitive Intelligence Brief. https://druglandscape.com/ci/vaccinated-with-sabin-ipv. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: